WHO ICTRP trial

The COMPLETE T1D Trial: COMParison of Insulin Lispro Protamine Suspension and…

EUCTR2006-006375-21-HU · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2006-006375-21-HU
Public title The COMPLETE T1D Trial: COMParison of Insulin Lispro Protamine Suspension and DETEmir in Type 1 Diabetes Comparison of Two Basal Insulin Analogs (Insulin Lispro Protamine Suspension and Insulin Detemir) in Basal-Bolus Therapy for Patients with Type 1 Diabetes - COMPLETE T1D Trial
Scientific title The COMPLETE T1D Trial: COMParison of Insulin Lispro Protamine Suspension and DETEmir in Type 1 Diabetes Comparison of Two Basal Insulin Analogs (Insulin Lispro Protamine Suspension and Insulin Detemir) in Basal-Bolus Therapy for Patients with Type 1 Diabetes - COMPLETE T1D Trial
Primary sponsor Eli Lilly and Company Ltd.
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Countries Hungary
Conditions type 1 diabetes MedDRA version: 8.1 Level: LLT Classification code 10045228 Term: Type I diabetes mellitus
Interventions Trade Name: Humalog NPL 100 U/ml suspension for injection in cartridge Product Name: Humalog NPL Pharmaceutical Form: Suspension for injection INN or Proposed INN: insulin lispro CAS Number: 133107-64-9 Current Sponsor code: LY275585[P]…
Registration date Feb 16, 2007
Target size 335
Secondary IDs F3Z-MC-IOOZ(a)
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations